DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Pfizer (NYSE: PFE)

35.27 -0.09 (-0.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $35.27 -0.25%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $35.20
Previous Close $35.36
Daily Range $35.05 - $35.40
52-Week Range $27.51 - $35.53
Market Cap $216.2B
P/E Ratio 25.08
Dividend (Yield) $1.12 (3.2%)
Ex-Dividend Date
Dividend Pay Date
05/06/15
06/02/15
Volume 22,801,317
Average Daily Volume 27,040,205
Current FY EPS $2.07

Sector

Healthcare

Industry

Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?

Immuno-oncology has become a major focus among big pharma companies these days. Should investors jump on this trend?

The Parade of Weak Earnings Reports Continues - Earnings Preview

After Hours Most Active for Apr 24, 2015 : CLF, QQQ, NRP, PFE, VALE, SBUX, LGCY, AAPL, ORCL, ETE, M

After Hours Most Active for Apr 24, 2015 : CLF, QQQ, NRP, PFE, VALE, SBUX, LGCY, AAPL, ORCL, ETE, MSFT, CSALV

Dogs Of The Dow March Quarter Roundup

Nurturing Your Portfolio With Mead Johnson

Pfizer's Once And Future Deals

Alnylam Strengthens Its Clinical Case Once Again

Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog

Pfizer On The Mission Of Developing Life-Saving Cancer Drugs

Pfenex Inc. Shifts Focus In-House To Develop Biosimilar To Betaseron

A Discussion Of Amgen's Q1 Results, With Updates On Its Pipeline

See More PFE News...

PFE's Top Competitors

PFE $35.27 (-0.25%)
Current stock: PFE
JNJ $101.08 (0.62%)
Current stock: JNJ
ROG $79.96 (-0.58%)
Current stock: ROG
GSK $46.59 (0.60%)
Current stock: GSK